Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1853 1
1870 1
1871 2
1945 1
1951 2
1952 2
1954 1
1964 1
1967 1
1968 4
1969 5
1970 8
1971 15
1972 13
1973 10
1974 6
1975 10
1976 9
1977 9
1978 9
1979 8
1980 13
1981 9
1982 4
1983 8
1984 11
1985 8
1986 10
1987 15
1988 33
1989 32
1990 44
1991 53
1992 45
1993 49
1994 49
1995 38
1996 63
1997 67
1998 102
1999 90
2000 82
2001 88
2002 108
2003 100
2004 127
2005 138
2006 168
2007 167
2008 183
2009 160
2010 213
2011 265
2012 297
2013 377
2014 545
2015 748
2016 851
2017 968
2018 1215
2019 1388
2020 1583
2021 1773
2022 1823
2023 1652
2024 1678
2025 714

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,152 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacology of Medical Cannabis.
Amin MR, Ali DW. Amin MR, et al. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. Adv Exp Med Biol. 2019. PMID: 31332738 Review.
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the clinic. The legalization of cannabis for medicinal purposes and for recreational use in some regions will allow for much needed rese …
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the …
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain.
Petzke F, Tölle T, Fitzcharles MA, Häuser W. Petzke F, et al. CNS Drugs. 2022 Jan;36(1):31-44. doi: 10.1007/s40263-021-00879-w. Epub 2021 Nov 21. CNS Drugs. 2022. PMID: 34802112 Free PMC article. Review.
Management of neuropathic pain presents an unmet clinical need, with less than 50% of patients achieving substantial pain relief with medications currently recommended such as pregabalin, gabapentin, duloxetine and various tricyclic antidepressants. It has been suggested that …
Management of neuropathic pain presents an unmet clinical need, with less than 50% of patients achieving substantial pain relief with medica …
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
Wang L, Hong PJ, May C, Rehman Y, Oparin Y, Hong CJ, Hong BY, AminiLari M, Gallo L, Kaushal A, Craigie S, Couban RJ, Kum E, Shanthanna H, Price I, Upadhye S, Ware MA, Campbell F, Buchbinder R, Agoritsas T, Busse JW. Wang L, et al. BMJ. 2021 Sep 8;374:n1034. doi: 10.1136/bmj.n1034. BMJ. 2021. PMID: 34497047
RESULTS: A total of 32 trials with 5174 adult patients were included, 29 of which compared medical cannabis or cannabinoids with placebo. Medical cannabis was administered orally (n=30) or topically (n=2). ...Medical cannabis taken orally …
RESULTS: A total of 32 trials with 5174 adult patients were included, 29 of which compared medical cannabis or cannabinoids wi …
Medical Cannabis: A plurimillennial history of an evergreen.
Pisanti S, Bifulco M. Pisanti S, et al. J Cell Physiol. 2019 Jun;234(6):8342-8351. doi: 10.1002/jcp.27725. Epub 2018 Nov 11. J Cell Physiol. 2019. PMID: 30417354 Review.
Its medical use is several thousand years old, as attested both by archeobotanical evidence of Cannabis remains and written records found in ancient texts from the sacred Vedic foundational texts of Ayurvedic medicine (about 800 before current era [BCE]) to the firs …
Its medical use is several thousand years old, as attested both by archeobotanical evidence of Cannabis remains and written re …
Medical Cannabis.
Ebbert JO, Scharf EL, Hurt RT. Ebbert JO, et al. Mayo Clin Proc. 2018 Dec;93(12):1842-1847. doi: 10.1016/j.mayocp.2018.09.005. Mayo Clin Proc. 2018. PMID: 30522595 Review.
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United States. Clinicians are increasingly being asked by patients to share information about or certify them for medical cannabis. In …
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United S …
Practical considerations in medical cannabis administration and dosing.
MacCallum CA, Russo EB. MacCallum CA, et al. Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4. Eur J Intern Med. 2018. PMID: 29307505 Review.
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certain nations, this ignorance of cannabis pharmacology and therapeutics has become untenable. ...Dose initiation should commence at modes …
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certai …
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.
Hill KP, Palastro MD. Hill KP, et al. Pol Arch Intern Med. 2017 Nov 30;127(11):785-789. doi: 10.20452/pamw.4123. Epub 2017 Oct 25. Pol Arch Intern Med. 2017. PMID: 29067992 Free article. Review.
We also reviewed the current state of evidence for cannabis and cannabinoids for several other medical conditions, while addressing the potential acute and chronic effects of cannabis use, which are issues that physicians must consider before making an offici …
We also reviewed the current state of evidence for cannabis and cannabinoids for several other medical conditions, while addre …
Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review.
Liang AL, Gingher EL, Coleman JS. Liang AL, et al. Obstet Gynecol. 2022 Feb 1;139(2):287-296. doi: 10.1097/AOG.0000000000004656. Obstet Gynecol. 2022. PMID: 35104069
A fatty acid amide called palmitoylethanolamide (PEA) enhances endogenous cannabinoids. Given that use of medical cannabis is increasing, we sought to characterize patterns of cannabis use for gynecologic pain and its effectiveness as an analgesic. ...However …
A fatty acid amide called palmitoylethanolamide (PEA) enhances endogenous cannabinoids. Given that use of medical cannabis is …
[Medical cannabis].
Kochen S. Kochen S. Salud Colect. 2022 Mar 3;18:e3991. doi: 10.18294/sc.2022.3991. Salud Colect. 2022. PMID: 35900986 Spanish.
In this issue, we take on alternatives regarding the use of medical cannabis from this perspective. Health research and its contribution to knowledge - in particular with respect to the development of new pharmaceuticals - represents not only a challenge related to …
In this issue, we take on alternatives regarding the use of medical cannabis from this perspective. Health research and its co …
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA, Raup-Konsavage WM, Vrana KE. Legare CA, et al. Pharmacology. 2022;107(3-4):131-149. doi: 10.1159/000521683. Epub 2022 Jan 28. Pharmacology. 2022. PMID: 35093949 Free article. Review.
While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (CBD oil, cannabis extracts, and/or cannabis itself). SUMMARY: In the pre …
While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited …
12,152 results
You have reached the last available page of results. Please see the User Guide for more information.